EUVIMEDEUVIMED entdecken
Fallbericht

Use of Botulinum Toxin for Effective Management of First Bite Syndrome Secondary to Malignancy: A Case Report

Hannah Bromberg, Jessica Ibanez

Journal of Palliative Medicine · 2024

DOI: 10.1089/jpm.2024.0081 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Palliative Medicine, 2024. Verfasst von Hannah Bromberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Supportive Care, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Botulinum Toxins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First bite syndrome may impact patients who have undergone treatment for head and neck malignancies as well as those who have had surgery in the parapharyngeal space. As the name suggests, upon salivating and/or taking the initial bites of a meal, severe, intense pain may result. Generally, as the patient continues to consume the meal, the symptoms will lessen but may still lead to decreased quality of life. While pharmacological options traditionally include anticonvulsants or tricyclic antidepressants, botulinum toxin injections are an effective alternative to pharmacotherapy. We report the case of a patient with squamous cell carcinoma of the head and neck who experienced first bite syndrome secondary to malignancy with noticeable response to botulinum toxin injections to the right masseter and temporalis muscles. Furthermore, we present this case, as it highlights a rare syndrome with various treatment options, including botulinum toxin, the latter without a predetermined treatment dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsHumansMaleBotulinum Toxins, Type ACarcinoma, Squamous CellHead and Neck NeoplasmsNeuromuscular AgentsSyndromeAdult

Stichwörter der Autor:innen

botulinum toxinfirst bite syndromehead and neck cancerparotid gland pain

Substanzen

Botulinum ToxinsBotulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Supportive Care, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Department of Anesthesiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Zitieren

APA

Bromberg, H., & Ibanez, J. (2024). Use of Botulinum Toxin for Effective Management of First Bite Syndrome Secondary to Malignancy: A Case Report. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2024.0081

Vancouver

Bromberg H, Ibanez J. Use of Botulinum Toxin for Effective Management of First Bite Syndrome Secondary to Malignancy: A Case Report. Journal of Palliative Medicine. 2024. doi:10.1089/jpm.2024.0081

BibTeX
@article{Bromberg2024,
  author = {Bromberg, Hannah and Ibanez, Jessica},
  title = {Use of Botulinum Toxin for Effective Management of First Bite Syndrome Secondary to Malignancy: A Case Report},
  journal = {Journal of Palliative Medicine},
  year = {2024},
  doi = {10.1089/jpm.2024.0081}
}
Kostenlos starten →